The miR-31-SOX10 axis regulates tumor growth and chemotherapy resistance of melanoma via PI3K/AKT pathway
Authors:
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 503 (4) , 2451-2458
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- SOX10 induced Nestin expression regulates cancer stem cell properties of TNBC cellsBiochemical and Biophysical Research Communications, 2017
- Sox10 Regulates Stem/Progenitor and Mesenchymal Cell States in Mammary Epithelial CellsCell Reports, 2015
- Diagnostic value of Sox10 immunohistochemical staining for the detection of metastatic melanoma in sentinel lymph nodesHistopathology, 2009
- Sox10: A Pan-Schwannian and Melanocytic MarkerAmerican Journal of Surgical Pathology, 2008
- Apoptosis pathways and oncolytic adenoviral vectors: promising targets and tools to overcome therapy resistance of malignant melanomaExperimental Dermatology, 2007
- Overcoming apoptosis deficiency of melanoma—Hope for new therapeutic approachesDrug Resistance Updates, 2007
- Combined treatment with Ad‐hTRAIL and DTIC or SAHA is associated with increased mitochondrial‐mediated apoptosis in human melanoma cell linesThe Journal of Gene Medicine, 2007
- Chemotherapy for metastatic melanomaCancer, 2007
- Complete metastasectomy in patients with stage IV metastatic melanomaThe Lancet Oncology, 2006
- From head to toes: the multiple facets of Sox proteinsNucleic Acids Research, 1999